Back to GetFilings.com




QuickLinks -- Click here to rapidly navigate through this document

United States
Securities and Exchange Commission
Washington, D.C. 20549


FORM 10-Q

Quarterly Report Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

For the Period Ended June 30, 2002

Commission File Number 1-14177

COBALT CORPORATION
(Exact name of registrant as specified in its charter)

Wisconsin
(State of incorporation)
39-1931212
(I.R.S. Employer Identification No.)

401 West Michigan Street, Milwaukee, Wisconsin
(Address of principal executive offices)

53203-2896
(Zip Code)

(414) 226-6900
(Registrant's telephone number, including area code)

        Indicate by check mark whether registrant (1) has filed all documents and reports required to be filed by Section 13, or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ý    No o

        Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practical date:

        Common stock outstanding as of July 31, 2002 was 41,106,890





COBALT CORPORATION

INDEX TO
QUARTERLY REPORT ON FORM 10-Q

For the Period Ended June 30, 2002

PART I    

Financial Statements and Supplementary Data

 

3

Management's Discussion and Analysis of Financial Condition and Results of Operations

 

17

Quantitative and Qualitative Disclosures about Market Risk

 

28

PART II

 

 

Other Information

 

29

Signature Page

 

32

2



PART I. FINANCIAL INFORMATION

Item 1. Financial Statements


COBALT CORPORATION
CONSOLIDATED BALANCE SHEETS

 
  June 30,
2002

  December 31,
2001

 
  (Unaudited)

   
 
  (In thousands)

ASSETS            

Current assets:

 

 

 

 

 

 
 
Cash and cash equivalents

 

$

67,478

 

$

51,669
  Investments—available-for-sale, at fair value     306,270     180,692
  Due from affiliates     5,859     5,091
  Premium receivables     33,989     33,486
  Due from clinics and providers     7,265     11,922
  Other receivables     47,067     49,138
  Prepaid expenses and other current assets     33,827     30,150
   
 
    Total current assets     501,755     362,148

Noncurrent assets:

 

 

 

 

 

 
 
Investments—held-to-maturity, at amortized cost

 

 

12,591

 

 

11,007
  Investments in affiliates, net     418     79,466
  Property and equipment, net     31,537     31,411
  Goodwill, net     89,594     92,066
  Prepaid pension     56,750     53,837
  Deferred income taxes     33,088     29,385
  Other noncurrent assets     68,914     48,685

Assets from discontinued operations

 

 


 

 

19,317
   
 

Total assets

 

$

794,647

 

$

727,322
   
 

See Notes to Interim Consolidated Financial Statements.

3



COBALT CORPORATION
CONSOLIDATED BALANCE SHEETS

 
  June 30,
2002

  December 31,
2001

 
 
  (Unaudited)

   
 
 
  (In thousands)

 
LIABILITIES AND SHAREHOLDERS' EQUITY              

Current liabilities:

 

 

 

 

 

 

 
 
Medical and other benefits payable

 

$

194,562

 

$

220,038

 
  Advance premiums     85,975     88,495  
  Due to affiliates     33     59  
  Payables and accrued expenses     72,527     49,582  
  Short-term debt     8,516     12,369  
  Other current liabilities     34,821     29,521  
   
 
 
    Total current liabilities     396,434     400,064  

Noncurrent liabilities:

 

 

 

 

 

 

 
 
Other benefits payable

 

 

50,094

 

 

47,282

 
  Deferred income taxes     33,088     29,259  
  Postretirement benefits other than pension     17,626     18,005  
  Other noncurrent liabilities     15,819     19,421  

Liabilities from discontinued operations

 

 


 

 

5,069

 
   
 
 
   
Total liabilities

 

 

513,061

 

 

519,100

 

Shareholders' equity (see Note H):

 

 

 

 

 

 

 
 
Common stock

 

 

255,006

 

 

249,566

 
  Retained earnings (deficit)     4,529     (41,979 )
  Accumulated other comprehensive income     22,051     635  
   
 
 
    Total shareholders' equity     281,586     208,222  
   
 
 
Total liabilities and shareholders' equity   $ 794,647   $ 727,322  
   
 
 

See Notes to Interim Consolidated Financial Statements.

4



COBALT CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)

 
  Three months ended
June 30,

  Six months ended
June 30,

 
 
  2002
  2001
  2002
  2001
 
 
  (In thousands, except share data)

 
Revenues:                          
  Health services revenue:                          
    Premium   $ 339,129   $ 366,883   $ 677,095   $ 516,905  
    Government contract fees     27,971     29,107     56,780     56,010  
    Other     12,150     11,541     23,414     19,243  
  Investment results     3,631     3,490     6,562     5,554  
   
 
 
 
 
    Total revenues     382,881     411,021     763,851     597,712  

Expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 
  Medical and other benefits     290,808     332,750     583,166     461,190  
  Selling, general, administrative and other     80,581     81,115     157,449     136,050  
  Interest     71     207     243     207  
  Amortization of goodwill         1,520         1,701  
   
 
 
 
 
    Total expenses     371,460     415,592     740,858     599,148  
   
 
 
 
 

Operating income (loss) from continuing operations

 

 

11,421

 

 

(4,571

)

 

22,993

 

 

(1,436

)
Income (loss) from investment in affiliates, net of tax     12,465     658     15,317     (1,193 )
   
 
 
 
 
Pretax income (loss) from continuing operations     23,886     (3,913 )   38,310     (2,629 )
Income tax expense     1,124     18     2,304     18  
   
 
 
 
 
Income (loss) from continuing operations     22,762     (3,931 )   36,006     (2,647 )
Income from discontinued operations:                          
  Income (loss) from discontinued operations, net of tax         135     (550 )   135  
  Gain (loss) on sale of discontinued operations, net of tax     (250 )       9,659      
   
 
 
 
 
Net income (loss)   $ 22,512   $ (3,796 ) $ 45,115   $ (2,512 )
   
 
 
 
 

Earnings (loss) per share (EPS):

 

 

 

 

 

 

 

 

 

 

 

 

 
  Basic EPS from continuing operations   $ 0.56   $ (0.09 ) $ 0.88   $ (0.07 )
  Basic EPS from discontinued operations     (0.01 )       0.23      
   
 
 
 
 
    Total basic EPS   $ 0.55   $ (0.09 ) $ 1.11   $ (0.07 )
   
 
 
 
 
 
Diluted EPS from continuing operations

 

$

0.54

 

$

(0.09

)

$

0.86

 

$

(0.07

)
  Diluted EPS from discontinued operations     (0.01 )       0.22      
   
 
 
 
 
    Total diluted EPS   $ 0.53   $ (0.09 ) $ 1.08   $ (0.07 )
   
 
 
 
 

See Notes to Interim Consolidated Financial Statements.

5



COBALT CORPORATION
CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME (LOSS)
(UNAUDITED)

 
  Common Shares
Outstanding

  Common
Stock

  Retained
Earnings
(Deficit)

  Accumulated Other
Comprehensive
Income (Loss)

  Total
Shareholders'
Equity

 
 
  (In thousands, except share data)

 
Balance at December 31, 2000     $   $ 170,907   $ (1,964 ) $ 168,943  
    Capitalization of Wisconsin United for Health Foundation, Inc.   31,313,390     192,577     (192,577 )        
  Issuance of common stock—acquisition   9,096,303     55,938             55,938  
  Issuance of common stock—options   11,250     51             51  
  Issuance of common stock—401(k)   172,100     1,000             1,000  
  Adjustments as a result of purchase accounting           82         82  
  Change in ownership of affiliates           1,320         1,320  
  Conversion of SAR's to options           594         594  
  Comprehensive loss:                              
    Net loss           (22,305 )       (22,305 )
    Change in unrealized gains/losses on investments, net of tax               2,599     2,599  
                         
 
      Comprehensive loss                           (19,706 )
   
 
 
 
 
 
Balance at December 31, 2001   40,593,043   $ 249,566   $ (41,979 ) $ 635   $ 208,222  
  Issuance of common stock—options   448,967     4,990             4,990  
  Issuance of common stock—401(k)   64,880     450             450  
  Change in ownership of affiliates           1,304         1,304  
  Conversion of SAR's to options—vesting           89         89  
  Comprehensive income:                              
    Net income           45,115         45,115  
    Change in unrealized gains/losses on investments, net of tax               21,416     21,416  
                         
 
      Comprehensive income                           66,531  
   
 
 
 
 
 
Balance at June 30, 2002   41,106,890   $ 255,006   $ 4,529   $ 22,051   $ 281,586  
   
 
 
 
 
 

See Notes to Interim Consolidated Financial Statements.

6



COBALT CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)

 
  Six months ended
June 30,

 
 
  2002
  2001
 
 
  (In thousands)

 
Operating activities:              
  Income (loss) from continuing operations   $ 36,006   $ (2,647 )
  Adjustments to reconcile income (loss) from continuing operations to net cash provided by (used in) operating activities:              
    Depreciation and amortization     5,510     7,563  
    (Income) loss from investment in affiliates, net of tax     (15,317 )   1,193  
    Realized investment gains, net     (27 )   (80 )
    Deferred income taxes     38     602  
    Changes in operating accounts, net of discontinued operations, acquisitions and conversion/combination related activity:              
      Premium receivables     (503 )   6,845  
      Other receivables     6,198     (5,420 )
      Due from clinics and providers     4,657     1,642  
      Medical and other benefits payable     (22,664 )   (14,211 )
      Advance premiums     (2,520 )   2,582  
      Due to/from affiliates, net     (794 )   (9,890 )
      Other, net     (8,877 )   4,418  
   
 
 
        Net cash provided by (used in) continuing operations     1,707     (7,403 )

Investing activities:

 

 

 

 

 

 

 
  Acquisitions and Combination activity         49,538  
  Proceeds from sale of investment in affiliate     68,436      
  Proceeds from sale of discontinued operations     17,000      
  Purchases of available-for-sale investments     (96,529 )   (75,921 )
  Purchases of held-to-maturity investments         (1,303 )
  Proceeds from maturity of held-to-maturity investments     245     250  
  Proceeds from sale and maturity of available-for-sale investments     32,130     63,430  
  Additions to property and equipment, net     (5,321 )   (2,561 )
  Dividends from affiliate     552      
   
 
 
        Net cash provided by investing activities     16,513     33,433  

Financing activities:

 

 

 

 

 

 

 
  Proceeds from issuance of common stock     3,963     38  
  Net (repayments) borrowings of debt     (6,853 )   4,335  
   
 
 
        Net cash provided by (used in) financing activities     (2,890 )   4,373  

Discontinued Operations:

 

 

 

 

 

 

 
  Cash flows from discontinued operations     479     (314 )
   
 
 
        Net cash provided by (used in) discontinued operations     479     (314 )

Cash and cash equivalents:

 

 

 

 

 

 

 
  Increase during the period     15,809     30,089  
  Balance at beginning of year     51,669     1,305  
   
 
 
        Balance at end of period   $ 67,478   $ 31,394  
   
 
 

See Notes to Interim Consolidated Financial Statements.

7



COBALT CORPORATION
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

June 30, 2002

Note A. Basis of Presentation

        The accompanying unaudited interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States ("GAAP") for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the three and six months ended June 30, 2002 are not necessarily indicative of the results that may be expected for the year ending December 31, 2002. These interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2001 and footnotes thereto included in the Cobalt Corporation ("Cobalt" or the "Company") Annual Report on Form 10-K for the year ended December 31, 2001, as filed with the Securities and Exchange Commission ("SEC").

        Cobalt (formerly known as United Wisconsin Services, Inc. ("UWS")) was created as a result of the combination of UWS and Blue Cross & Blue Shield United of Wisconsin ("BCBSUW") on March 23, 2001 (the "Combination"). On that date, BCBSUW converted from a service insurance corporation to a stockholder owned corporation. Upon conversion, BCBSUW became a wholly-owned subsidiary of UWS through the combination of the two companies. At the time of conversion and the Combination, BCBSUW owned approximately 46.6% of UWS' outstanding common stock. In exchange for the ownership of BCBSUW, Cobalt issued 31,313,390 shares of newly issued Company common stock to Wisconsin United for Health Foundation, Inc. (the "Foundation"). The Foundation was established for the sole purpose of benefiting public health in Wisconsin from its earnings in the investment in Cobalt.

        The Combination was accounted for as a purchase by BCBSUW of the remaining 9,096,303 shares of UWS that it did not already own at a market price of $6.15 per share on the closing date. In accordance with GAAP, goodwill was recorded representing the excess of the market price over the adjusted book value of UWS for the 53.4% of UWS that BCBSUW did not already own. For reporting purposes, the Combination is treated as a reverse purchase transaction, whereby BCBSUW becomes the acquirer and reporting entity for public company reporting. The consolidated statements of operations, cash flows, and changes in shareholders' equity and comprehensive income (loss) for the three and six month periods ended June 30, 2002 reflect the operations of the combined UWS and BCBSUW entities. Results for the three month period ended March 31, 2001, which are reflected in the consolidated financial statements for the six months ended June 30, 2001, include only the operations of BCBSUW and its wholly-owned subsidiary, United Government Services, LLC ("UGS") and minority interest in UWS and American Medical Security Group, Inc. ("AMSG"). Results for the three month period ended June 30, 2001, included in the consolidated financial statements for the six months ended June 30, 2001, reflect the operations of the combined UWS and BCBSUW entities. For purposes of calculating earnings per common share ("EPS") of the Company, the 7,949,904 shares of Cobalt common stock owned by BCBSUW are accounted for as treasury stock. The pro forma statement of operations for the six months ended June 30, 2001 for Cobalt presented in Note E, includes the operations of the former UWS and BCBSUW with elimination of intracompany transactions, the recording of purchase accounting adjustments and the amortization of goodwill calculated as if the transaction was completed at the beginning of the reporting period.

8


        Continuing operations in the consolidated financial statements subsequent to the Combination include the accounts of the Company's majority owned insurance subsidiaries (BCBSUW, Compcare Health Services Insurance Corporation ("CompcareBlue"), Unity Health Plans Insurance Corporation ("Unity"), Valley Health Plan, Inc. ("Valley"), United Wisconsin Insurance Company ("UWIC"), and United Heartland Life Insurance Company ("UHLIC")) and other non-insurance subsidiaries (UGS, Meridian Resource Company, LLC ("MRC"), Comprehensive Receivables Group, Inc. ("CRG"), United Wisconsin Proservices, Inc. ("Proservices"), United Heartland, Inc. ("UHI") and C.C. Holdings, LLC ("CC Holdings")). All intracompany transactions after March 31, 2001 have been eliminated in consolidation.

Note B. Discontinued Operations

        On March 29, 2002, Cobalt and certain affiliates sold 100% of the membership interest of its subsidiary, Innovative Resource Group, LLC ("IRG"), for $27.0 million ($17.0 million in cash and $10.0 million in a three-year note). IRG was one of Cobalt's specialty companies, which provided behavioral health and medical management services. Accordingly, IRG is accounted for as a discontinued operation for all periods presented. The purchase agreement also provides for certain bonuses/penalties to be received/paid between IRG and Cobalt based on revenues generated from Cobalt and affiliated entities in future years. In addition, the agreement requires certain subsidiaries of Cobalt to enter into seven-year service agreements for the provision of services by IRG.

        The net gain on disposition of discontinued operations was $9.1 million, which includes a realized gain on the sale of $9.6 million, offset by a $0.5 million loss on IRG's operations for the six months ended June 30, 2002. During the second quarter of 2002, additional expenses of $0.3 million, related to the sale, were recorded adjusting the original gain down to $9.6 million from $9.9 million. The net gain on the sale could be adjusted further, based on any payments made in future periods in accordance with the purchase and sale agreement. Income from discontinued operations amounted to $0.1 million for the three and six month periods ended June 30, 2001. This reflects activity for the second quarter of 2001 only, since IRG was not considered part of Cobalt for financial reporting purposes prior to the Combination.

Note C. Net Income (Loss) Per Share

 
  Three months ended
June 30,

  Six months ended
June 30,

 
 
  2002
  2001
  2002
  2001
 
 
  (unaudited)

 
Numerator (in thousands):                          
  Net income (loss)   $ 22,512   $ (3,796 ) $ 45,115   $ (2,512 )
   
 
 
 
 
Denominator:                          
  Denominator for basic EPS—weighted average shares     40,904,010     40,415,278     40,771,339     36,341,914  
  Effect of dilutive securities—employee stock options     1,509,543         988,952      
   
 
 
 
 
Denominator for diluted EPS     42,413,553     40,415,278     41,760,291     36,341,914  
   
 
 
 
 

Earnings (loss) per common share: